Clinical Trial Update: Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating polymyxin E (colistin) therapy for pneumonia caused by carbapenem-resistant Gram-negative bacteria, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Polymyxin E (Colistin) (polymyxin E)

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: Lung Infection Bacterial | Phase 4 | Status: ENROLLING_BY_INVITATION